Siren Biotechnology

Cairn Biosciences is a San Francisco-based biotech company that specializes in discovering new medicines by mapping multiscale cell dynamics. Their proprietary COMPASS discovery platform utilizes innovative simulations of living biology to navigate complex disease biology and unlock exclusive routes to novel targets and drugs, with a focus on overcoming acquired resistance to targeted cancer therapies. With a diverse and multidisciplinary team of experts in drug discovery, disease biology, engineering, and computation, Cairn Biosciences is pioneering a new drug discovery paradigm. Their team, led by established biopharma leader and serial drug discovery innovator Mary Ludlam, is dedicated to delivering better therapeutics through their expertise in synthetic cell biology, high-throughput microscopy, computational analysis, and more.Generated from the website

Atom Research Alliance is a cutting-edge research facility based in San Francisco, CA. Specializing in atomic and molecular research, the company is dedicated to advancing scientific knowledge in the field. With a team of skilled scientists and state-of-the-art equipment, Atom Research Alliance conducts experiments and studies to explore the fundamental building blocks of matter. Their work contributes to the development of new technologies and innovations in the scientific community. Generated from their business information

Vir Biotechnology, Inc. is a San Francisco-based company dedicated to harnessing the power of the immune system to develop innovative therapies that address significant unmet medical needs, particularly in infectious diseases and cancer. With proprietary technology platforms, including next-generation antibodies and PRO-XTEN protease-releasable masking technology, Vir focuses on advancing therapeutic candidates from concept to clinic, notably in chronic hepatitis delta, COVID-19, and Ebola. Led by a seasoned management team, Vir Biotechnology is committed to delivering transformative medicines for patients worldwide. The company actively seeks to engage talented individuals who share its mission of improving patient outcomes through groundbreaking immunological advancements. Generated from the website